Buy or sell Nuclera Nucleics stock pre IPO via an EquityZen fund
Nuclera Nucleics Stock
Enzymatic DNA synthesis
About Nuclera Nucleics Stock
Nuclera is a next-generation DNA synthesis company creating tailored solutions for the synthetic biology, industrial enzyme engineering, and pharmaceutical industries. Our proprietary enzyme-mediated DNA synthesis platform will enable the rapid and cost-effective production of highly accurate, ultra-long DNA strands. We aim to be the key provider of long-length variant DNA and genome libraries for protein, biological pathway, and ultimately genome-scale engineering.